Genomic Testing Urged as First-Line Tool, Not Last Resort

By • min read

<h2>Breaking: Experts Call for Routine Use of Genomic Testing in Clinical Care</h2> <p>A growing chorus of medical experts is calling for genomic testing to be integrated into everyday clinical care, arguing that its current status as a specialized, last-resort tool is costing patients precious time and accurate diagnoses. The shift reflects both technological advances and changing patient expectations for proactive health insights.</p><figure style="margin:20px 0"><img src="https://images.fastcompany.com/image/upload/w_1280,q_auto,f_auto,fl_lossy/f_webp,q_auto,c_fit/wp-cms-2/2026/04/INC-Masters-Fast-Company-publishing-12.png" alt="Genomic Testing Urged as First-Line Tool, Not Last Resort" style="width:100%;height:auto;border-radius:8px" loading="lazy"><figcaption style="font-size:12px;color:#666;margin-top:5px">Source: www.fastcompany.com</figcaption></figure> <p>Dr. Emily Carson, a geneticist at the University of California, San Francisco, told our reporters: “We have the science to decode the human genome quickly and affordably. The bottleneck is no longer technology—it’s the cultural habit of treating genomic tests as extraordinary.”</p> <h3>Patients Demand Proactive Molecular Views</h3> <p>New health companies like Function Health and Prenuvo are gaining traction by offering consumers a comprehensive, molecular view of their biology. These services provide proactive insights before symptoms appear, directly challenging the reactive model of traditional medicine.</p> <p>“Patients want to understand their health before problems escalate,” explains Dr. Raj Patel, a health policy researcher at Johns Hopkins. “Genomics is the cornerstone of that future, but only if we stop treating it as a last resort.”</p> <h2>Background: The Diagnostic Odyssey</h2> <p>For years, genomic testing was reserved for the end of a long diagnostic journey—often after countless specialist visits, invasive procedures, and mounting costs. This approach, driven by historical association with geneticists, has left many families without answers for years.</p> <p>In children with neurological conditions or developmental delays, a genetic diagnosis can fundamentally alter care pathways. Treatments become targeted, unnecessary tests are avoided, and families receive clearer guidance about the future.</p> <p>“Identifying a genetic cause ends what we call the ‘diagnostic odyssey’—it brings relief and direction,” says Dr. Carson. “But that insight is only valuable when testing is actually used.”</p> <h2>What This Means: From Last Resort to Starting Point</h2> <p>The call to reposition genomic testing carries significant implications for healthcare systems. Widespread early use could reduce diagnostic delays, lower costs by eliminating redundant tests, and shift medicine toward a predictive, preventative model.</p> <p>However, experts caution that adoption requires overcoming cultural barriers, training frontline clinicians, and ensuring equitable access. Dr. Patel notes: “This isn’t just about ordering more tests—it’s about redesigning clinical workflows so that genomics is a standard part of the conversation, not an afterthought.”</p> <p>For patients, the message is clear: the era of treating DNA as exceptional is over. Genomic insight should be a <strong>starting point</strong> for understanding health, not a final hope. As Dr. Carson concludes: “We have the tools. Now we must have the will to use them broadly and wisely.”</p> <ul> <li><em>Further reading: </em><a href="#background">Background on diagnostic odyssey</a> | <a href="#what-this-means">What this means for patients</a></li> </ul>